No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleonly females |
293145 |
2. Check conditionsNone |
293145 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
166 |
4. Check minimum number of eventsNone |
166 |
5. Include endpointsNone |
166 |
6. Filter based on genotype QC (FinnGen only) |
158 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Adenocarcinomas of cervix
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of cervix uteri
- Malignant neoplasm of cervix uteri, including Hilmo
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, including Hilmo
- Solid cancers
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 158 | 158 | - |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | - |
| Median age at first event (years) | 42.65 | 42.65 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 166
- Matched controls
- 1660
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
135.7
111
*
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
129.8
107
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
28.1
97.2
79
52
ULA02
NOMESCO Finland
Kolposcopy
14.8
71.5
103
165
128
Kela drug reimbursment
Cancers of female genital organs
+∞
61.3
55
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
11.9
59.9
100
187
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
+∞
54.2
49
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
9.7
48.3
84
159
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
46.0
42
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
43.7
40
*
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
+∞
43.7
40
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
9.2
40.6
64
106
H02AB02
ATC
dexamethasone; systemic
111.4
40.0
42
5
JN4BD
NOMESCO Finland
Extensive body CT
16.7
39.5
36
27
XX3DW
NOMESCO Finland
Time consuming IT work
15.6
37.0
35
28
A04AA01
ATC
ondansetron; systemic, rectal
16.2
36.8
34
26
LDA10
NOMESCO Finland
Curettage of cervix uteri
11.0
35.2
43
51
LEB00
NOMESCO Finland
Biopsy of vagina
47.3
33.4
40
11
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
30.1
28
*
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
98.0
30.0
32
*
B01AB10
ATC
tinzaparin; parenteral
8.0
29.7
49
83
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
12.5
28.9
31
30
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
334.8
28.7
28
*
ZXC96
NOMESCO Finland
Robot assisted procedure
75.6
28.1
31
5
WF002
NOMESCO Finland
Radical radiotherapy
111.5
26.6
28
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
11.0
26.5
31
34
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.1
25.7
36
18
C53.0
ICD-10 Finland
Malignant neoplasm: Endocervix
+∞
24.6
23
*
LCD30
NOMESCO Finland
Radical hysterectomy
+∞
24.6
23
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
47.6
23.5
28
7
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
23.5
22
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.1
23.0
69
202
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
251.8
22.2
22
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
21.3
20
*
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
21.3
20
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.6
21.2
92
355
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
20.2
19
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
20.4
19.6
29
17
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
19.1
18
*
A04AA02
ATC
granisetron; systemic, transdermal
213.1
18.9
19
*
B01AB05
ATC
enoxaparin; parenteral
4.2
18.6
83
321
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
18.0
17
*
JN4AD
NOMESCO Finland
Body CT examination
8.2
17.5
25
35
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
23.1
17.0
24
12
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
17.0
16
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
94.2
15.9
17
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.2
15.6
53
165
UKC02
NOMESCO Finland
Cystoscopy
5.2
15.5
37
87
TPH07
NOMESCO Finland
Cathetrisation of artery
5.9
15.5
31
62
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
35.5
15.2
19
6
L03AA13
ATC
pegfilgrastim; parenteral
+∞
14.8
14
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
14.8
14
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
14.8
14
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
14.8
14
*
C53.09
ICD-10 Finland
Malignant tumor of endocervix, unspecified histology
+∞
13.7
13
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
13.7
13
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
151.9
13.7
14
*
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
10.8
13.6
26
28
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
19.3
12.9
19
11
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.7
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.7
12
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.5
12.0
55
207
1800A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Endocervix
+∞
11.6
11
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
11.6
11
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
11.6
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.6
11
*
C53.92
ICD-10 Finland
Adenocarcinoma in an unspecified location in the cervix
+∞
11.6
11
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
128.6
11.6
12
*
LCA06
NOMESCO Finland
Biopsy of endometrium
3.6
11.5
47
164
WX302
NOMESCO Finland
Thoracal epidural anesthesy
15.6
10.7
17
12
JN3AD
NOMESCO Finland
Abdominal CT examination
4.0
10.5
34
100
C53
ICD-10 Finland
Malignant neoplasm of cervix uteri
+∞
10.5
10
*
8310
FHL
Radical hysterectomy (includes lymph node removal)
+∞
10.5
10
*
8140/3-C53.1
ICD-O-3
Adenocarcinoma, NOS, of exocervix
+∞
10.5
10
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.9
9.8
32
95
WX402
NOMESCO Finland
General anaesthesia
3.1
9.5
51
208
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
9.5
9
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
9.5
9
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
9.5
9
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
9.3
93
527
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.8
9.2
22
51
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
39.0
9.1
11
*
Z51.5
ICD-10 Finland
Palliative care
9.0
8.8
18
22
WZC30
NOMESCO Finland
Teaching
3.6
8.7
32
103
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
94.7
8.5
9
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
94.7
8.5
9
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.3
8.4
18
24
LBE10
NOMESCO Finland
Bilateral salpingectomy
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
LAG11
NOMESCO Finland
Laparoscopic oophoropexy
+∞
8.4
8
*
C53.1
ICD-10 Finland
Malignant neoplasm: Exocervix
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
+∞
8.4
8
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
16.0
7.8
12
8
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
16.0
7.8
12
8
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
47.2
7.8
9
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
47.2
7.8
9
*
WW500
NOMESCO Finland
Blood transfusion
9.6
7.7
15
17
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.4
7.5
29
96
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
83.7
7.5
8
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.1
7.5
22
60
C53.9
ICD-10 Finland
Malignant neoplasm: Cervix uteri, unspecified
+∞
7.3
7
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
C53.90
ICD-10 Finland
Malignant tumor in unspecified localization in cervix uteri without histology
+∞
7.3
7
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
31.5
7.2
9
*
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
31.5
7.2
9
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.8
7.2
12
10
J01EA01
ATC
trimethoprim; systemic
2.4
7.1
71
389
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
8.1
7.1
15
20
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.7
6.9
15
21
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.7
6.7
44
197
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
72.5
6.5
7
*
KA1FN
NOMESCO Finland
Isotope renography
72.5
6.5
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
49
93
7.06
26.55
2.6
1.5
—
—
—
0
0
95
416
4.00
17.53
2.6
1.5
—
—
—
0
0
112
662
3.13
10.91
3.1
2.4
—
—
estimate
—
0
0
91
486
2.93
10.57
4.3
3.1
—
—
—
0
0
36
112
3.83
10.31
2.3
3.1
—
—
—
0
0
98
579
2.69
8.86
6.7
3.7
34.86
36.81
g/l
2.52
91
541
117
790
2.63
7.53
14.7
6.7
4.02
4.18
e9/l
0.28
107
674
29
97
3.41
7.36
2.8
2.6
0.26
0.21
g/l
2.94
29
91
29
98
3.37
7.24
1.9
1.5
—
—
—
0
0
120
833
2.59
7.07
5.7
3.8
0.00
0.00
estimate
-0.00
32
155
103
680
2.36
6.59
8.7
3.4
8.21
10.05
umol/l
2.58
96
639
22
67
3.63
6.40
4.1
1.6
3.03
3.10
ug/l
0.03
17
49
117
830
2.39
6.14
5.6
3.9
0.00
0.00
estimate
-0.00
33
159
68
394
2.23
5.75
4.2
2.8
0.53
0.45
e6/l
0.18
53
266
132
1002
2.55
5.73
7.1
5.1
2638.29
3566.44
e6/l
—
7
16
73
439
2.18
5.59
5.7
4.0
0.00
0.00
estimate
-0.00
32
150
114
819
2.25
5.52
5.8
3.9
0.00
0.00
estimate
-0.00
33
157
134
1061
2.36
4.68
10.5
5.4
83.77
76.23
u/l
0.70
127
983
55
328
2.01
4.08
2.4
1.8
—
—
—
0
0
43
243
2.04
3.66
3.6
2.6
0.76
1.37
e6/l
0.94
23
109
87
623
1.83
3.61
5.3
3.7
0.00
0.00
estimate
-0.00
30
123
65
436
1.81
3.26
3.7
2.3
49.53
56.84
u/l
1.44
59
405
103
791
1.80
3.26
4.5
3.9
6.36
6.43
mmol/l
0.15
97
736
11
30
3.85
3.15
1.3
1.5
—
—
—
0
0
24
116
2.25
3.01
4.9
5.2
0.83
1.05
mmol/l
0.15
18
98
16
65
2.62
2.89
4.9
6.3
0.71
0.63
%
0.45
16
65
16
67
2.54
2.73
5.0
6.2
1.37
1.20
%
0.45
16
67
12
41
3.07
2.68
1.3
1.2
—
—
—
0
0
37
225
1.83
2.49
3.9
2.9
2.45
5.23
e6/l
1.27
20
90
28
156
1.96
2.45
6.4
4.4
104.50
104.44
mmol/l
0.02
28
156
15
65
2.44
2.39
5.3
6.4
96.25
94.84
%
2.21
15
65
10
34
3.06
2.32
2.0
1.4
0.95
0.90
ug/l
—
10
27
78
595
1.59
2.23
5.6
4.6
1.21
1.22
mmol/l
0.28
71
541
86
682
1.54
2.01
6.1
4.9
1.21
1.22
mmol/l
0.84
73
593
25
144
1.87
1.99
7.5
5.6
—
—
—
0
0
17
86
2.09
1.93
3.0
2.5
265.24
3108.92
u/l
—
10
39
55
402
1.55
1.83
2.7
2.3
3.19
2.77
mg/l
0.48
49
352
16
82
2.05
1.76
1.9
1.4
—
—
—
0
0
23
135
1.82
1.73
1.7
1.6
—
—
—
0
0
5
13
3.93
1.72
1.2
1.2
—
—
—
0
0
59
444
1.51
1.70
1.6
1.6
21.22
22.00
nmol/l
0.15
52
386
61
463
1.50
1.69
4.6
3.1
0.00
0.00
estimate
-0.00
31
125
18
102
1.86
1.52
2.9
3.0
0.34
0.31
e6/l
0.05
18
96
23
141
1.73
1.51
1.7
1.6
—
—
—
0
0
6
22
2.79
1.45
1.0
1.2
—
—
—
0
0
13
67
2.02
1.42
1.5
1.4
—
—
—
0
0
50
377
1.47
1.40
5.1
4.1
1.02
1.02
kg/l
0.33
36
249
29
200
1.55
1.23
1.7
1.7
—
—
—
0
0
6
26
2.36
1.19
1.0
1.2
—
—
—
0
0
6
26
2.36
1.19
1.0
1.2
—
—
—
0
0
137
1458
0.65
1.18
4.0
4.7
4.94
4.74
mmol/l
1.69
127
1377
7
30
2.39
1.14
1.4
2.0
4.33
3.55
g/l
—
7
30
153
1448
1.72
1.07
22.2
12.3
32.90
18.80
mg/l
4.84
137
1141
28
382
0.68
1.06
1.3
1.4
133.91
32.98
iu/ml
—
7
104
11
61
1.86
1.01
1.4
1.5
—
—
—
0
0
137
1449
0.69
0.97
3.9
4.7
1.62
1.57
mmol/l
0.68
127
1361
12
193
0.59
0.94
1.8
1.9
—
—
—
0
0
128
1367
0.72
0.93
4.6
5.9
37.33
38.40
mmol/mol
0.72
120
1297
135
1428
0.71
0.90
4.3
4.7
5.59
5.74
mmol/l
1.14
124
1330
12
74
1.67
0.80
1.4
1.9
—
—
—
0
0
0
27
0.00
0.78
0.0
1.0
—
2.90
—
0
6
55
646
0.78
0.77
1.9
1.8
1.30
1.29
mmol/l
0.02
49
569
5
25
2.03
0.73
1.0
1.1
—
—
—
0
0
5
26
1.95
0.71
1.0
2.0
—
—
—
0
0
93
1019
0.80
0.69
3.4
3.0
52.60
36.03
u/l
0.81
87
968
7
43
1.65
0.67
1.0
1.5
60.32
45.39
ug/l
—
7
43
82
732
1.24
0.66
2.5
2.6
71.83
77.17
nmol/l
1.39
73
669
141
1469
0.73
0.66
4.5
5.4
2.88
2.76
mmol/l
0.87
131
1382
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
13
91
1.46
0.55
5.3
1.9
48.83
74.21
ml/min/173m2
—
6
39
33
395
0.79
0.52
1.6
1.7
—
—
—
0
0
9
64
1.43
0.52
1.1
1.2
—
—
—
0
0
11
154
0.69
0.49
1.7
1.8
—
—
—
0
0
29
349
0.80
0.48
1.1
1.3
36.54
7.87
u/ml
—
9
140
7
48
1.48
0.47
1.0
1.1
—
6.78
—
0
8
10
69
1.48
0.45
2.3
2.4
0.63
0.61
%
—
10
69
8
57
1.42
0.43
1.3
1.1
1.57
1.62
g/l
—
8
57
10
70
1.46
0.43
2.3
2.4
1.33
1.19
%
—
10
70
58
519
1.18
0.42
3.3
3.4
28.28
19.82
ng/l
0.44
31
313
8
58
1.40
0.42
1.3
1.1
0.84
0.83
g/l
—
8
58
0
15
0.00
0.41
0.0
1.1
—
14.10
—
0
8
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
140
1445
0.80
0.41
6.4
5.9
1.89
1.77
mu/l
0.21
127
1367
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
132
1370
0.82
0.41
3.2
4.0
1.29
1.19
mmol/l
0.91
122
1270
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
2.3
—
13.34
—
0
17
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
112.19
—
0
17
11
148
0.73
0.40
1.4
1.5
1098.69
973.16
mu/l
0.17
11
122
75
688
1.16
0.40
2.1
2.1
96.21
99.08
pmol/l
0.25
45
346
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
144
1395
1.24
0.37
21.8
11.1
84.55
84.69
ml/min/173m2
0.02
136
1262
110
1044
1.16
0.36
3.6
3.8
—
—
—
0
0
15
119
1.29
0.33
4.7
3.4
4.53
4.57
pmol/l
0.06
15
109
30
263
1.17
0.28
5.9
4.0
483.09
66.78
ng/l
0.66
22
176
8
64
1.26
0.28
1.1
1.2
—
—
—
0
0
8
65
1.24
0.27
1.4
1.5
—
—
—
0
0
41
450
0.88
0.25
5.1
4.0
19.25
6.48
mg/mmol
0.87
27
268
5
40
1.26
0.22
1.0
1.2
—
—
—
0
0
11
134
0.81
0.21
2.5
2.4
—
10.21
—
0
8
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
9
113
0.78
0.20
1.2
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
46
427
1.11
0.19
1.5
1.3
0.61
0.99
u/ml
0.95
22
122
6
52
1.16
0.19
1.5
1.7
—
—
—
0
0
155
1532
1.18
0.14
15.2
9.5
22.33
22.61
u/l
0.12
150
1486
125
1274
0.92
0.13
5.6
4.9
14.72
14.52
pmol/l
0.39
114
1192
5
45
1.11
0.10
2.0
1.4
—
0.01
—
0
6
6
56
1.07
0.09
1.5
1.7
—
—
—
0
0
38
365
1.05
0.06
1.9
1.7
2.87
1.02
mg/l
0.46
28
283
10
110
0.90
0.05
1.2
1.4
—
—
—
0
0
26
272
0.95
0.05
2.2
2.0
—
—
—
0
0
12
113
1.07
0.02
1.0
1.1
—
—
—
0
0
25
243
1.03
0.01
2.1
1.9
—
—
—
0
0
19
191
0.99
0.00
1.4
1.9
3.09
3.32
ratio
0.42
14
147
15
153
0.98
0.00
1.3
1.8
3.70
3.47
mmol/l
—
9
107
6
65
0.92
0.00
3.2
3.4
58.40
45.99
%
—
6
65
0
7
0.00
0.00
0.0
2.0
—
42.00
—
0
7
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
63.07
—
0
7
6
63
0.95
0.00
2.7
2.7
24.05
25.13
mmol/l
—
6
63
0
9
0.00
0.00
0.0
1.4
—
76.84
—
0
9
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
6.99
—
0
7
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
5
54
0.92
-0.00
1.4
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.29
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
230.00
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CERVIX_ADENO – Adenocarcinomas of cervix
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).